MDAI (Spectral AI) Research & Development: $0.00 Mil (TTM As of Mar. 2026)


MDAI Spectral AI Inc MDAI
6 GF Score
Price $1.72
GF Value $0.91
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Spectral AI Research & Development?

Spectral AI MDAI -0.58% 6 Research & Development is $0.00 Mil as of Mar. 2026. GuruFocus rates MDAI with a GF Score™ of 6/100 and a GF Value™ of $0.91 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Spectral AI's Research & Development for the three months ended in Mar. 2026 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00 Mil.

Spectral AI  (NAS:MDAI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Spectral AI Research & Development Related Terms

Spectral AI Research & Development Historical Data

* Premium members only.

The historical data trend for Spectral AI's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spectral AI Research & Development Chart

Spectral AI Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
0.00 0.00 0.00 0.00 0.00

Spectral AI Quarterly Data
Dec21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MDAI
6GF Score
Spectral AI Inc MDAI
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Spectral AI Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Spectral AI (MDAI) has a Research & Development of $0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Spectral AI and its competitors.
Is Spectral AI's Research & Development too high?
Spectral AI's current Research & Development is $0.00 Mil. Overall, Spectral AI has a GF Score™ of 6/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Spectral AI's Research & Development compare to LUNG and QTI?
Spectral AI's Research & Development of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Spectral AI and its competitors. Spectral AI's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spectral AI stock overvalued right now?
Based on GuruFocus' analysis, Spectral AI (MDAI) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.91, compared to a current price of $1.72 — trading 89% above its estimated fair value. The current Research & Development is $0.00 Mil. Spectral AI's overall GF Score™ is 6/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Spectral AI (MDAI), the current Research & Development is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Spectral AI (MDAI) Overvalued in 2026?

Based on GuruFocus' analysis, Spectral AI stock appears to be overvalued. The current stock price of $1.72 is trading 89% above its estimated GF Value™ of $0.91. GuruFocus considers Spectral AI to be Significantly Overvalued.

Key valuation signals for MDAI:

  • Research & Development: $0.00 Mil
  • GF Value™: $0.91 vs. price of $1.72 (89% above fair value)
  • GF Score™: 6/100 with 4 warning signs

No single metric tells the full story. See the MDAI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Spectral AI Business Description

Address 2515 McKinney Avenue, Suite 1000, Dallas, TX, USA, 75201
Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.
6GF Score

Get the complete analysis for MDAI

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.72
Price
$0.91
GF Value